Navigating the
Objection
You're a pharmaceutical sales representative for a major healthcare distributor. Your prospect — a hospital pharmacy director — is ready to walk away. Your decisions over the next three conversations will determine whether you save the deal.
Dr. Walsh, Pharmacy Director
"Look, I appreciate the call, but I'll be honest — we've been with our current distributor for four years and I don't see a reason to change. Switching would be a major operational disruption for us. Unless you're offering something significantly different, I'm not sure this is worth our time."How do you respond?
Why this works: Acknowledging the concern before responding shows you heard her — not just waited to talk. Asking what "significantly different" means turns a vague objection into a specific, solvable problem. You've bought yourself critical intelligence.
What happened: Jumping straight to features and price before understanding her concern signals that you weren't listening. Dr. Walsh's objection was about disruption risk — not about cost. Pitching benefits she didn't ask about makes you sound like every other rep she's dismissed.
What happened: Deferring to a proposal is safe but passive. You've lost the momentum of the live conversation. Dr. Walsh is busy — another call risks never happening. You needed to engage the objection now, while you have her attention.
Dr. Walsh
"Our main issue has been specialty medication availability — particularly oncology. We had two significant fulfillment gaps last year that affected patient care. That's not acceptable, and frankly it's made me skeptical of any distributor's promises."How do you respond?
Why this works: You validated the emotional weight of the problem (patient care) before pivoting to evidence. Offering third-party proof — a reference customer — is far more credible than any claim you make about yourself. You've shifted from selling to consulting.
What happened: Blanket reassurances after a patient-care failure feel tone-deaf. "We've never had that issue" is impossible to verify and sounds defensive. You've given her no reason to believe you — and a reason to trust you less.
What happened: ROI framing is valuable — but jumping to the CFO's perspective before fully validating Dr. Walsh's clinical concern can feel transactional when she's just told you this affected patient care. Earn the trust first, then build the business case together.
Dr. Walsh
"I'll be honest — the data is compelling and the reference call was reassuring. My concern now is the transition itself. Our team is stretched thin and a bumpy switch could set us back months. I need to know this won't be a project that lands in my lap."How do you close?
Why this works: A structured pilot with a dedicated implementation team directly addresses her concern — her team's bandwidth — without asking her to take the risk on faith. Making the next step small and measurable removes the biggest barrier to yes. You've turned a high-stakes decision into a low-risk proof point.
What happened: "Always smooth" is another unverifiable promise — and you've already learned she doesn't trust claims without evidence. A discount signals that you're not confident the value is there without a price cut. You've addressed her concern with exactly what didn't work before.
What happened: Bringing in the operations director is the right eventual move — but scheduling another meeting before proposing a solution leaves Dr. Walsh without a reason to stay engaged. Propose the pilot first, then suggest including operations in the scoping call.
Scenario complete.
You navigated all three decision points using active listening, evidence-based trust-building, and a low-risk close. Dr. Walsh has agreed to a 90-day pilot.